drugset / Trial / NCT04013438
Luteal Phase Support During Frozen Embryo Transfer Cycle
RandomizedParallel-groupDouble-blindTreatment
Summary
We aimed to decrease quantity of exogenous estrogen and evaluated the success rate of ongoing pregnancy in women undergone artificial FET who have a surplus embryos at previous fertility treatment cycles. In this study, endometrial prepared with standard long GnRH protocol and for luteal phase support patients received 6 mg oral E2 and intramuscularly P 100 mg/d and embryos on day 2-3 were transferred. Control group continued E2 until 12 week of pregnancy, while for cases after identify gestational sac with heart beat (the 6 week of pregnancy) by vaginal ultrasonography, E2 will discontinued.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2019-01-01
- Completion
- 2019-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Strogen | Unknown | 6 mg | Oral |